Studies by Wei et al. demonstrated the role of KIF2C in the positive regulation of mTORC1 signaling in hepatocellular carcinoma, indicating that an mTOR inhibitor could be a potential therapeutic intervention in hepatocellular carcinoma62. This evidence concerns the gene MTOR and hepatocellular carcinoma.